French registry monitors liver cancer treatment in daily practice

NCT ID NCT03256994

Completed Knowledge-focused Sponsor: Cardiovascular and Interventional Radiological Society of Europe Source: ClinicalTrials.gov ↗

First seen Feb 05, 2026 · Last updated May 16, 2026 · Updated 13 times

Summary

This study is a registry that collected information on how SIR-Spheres (tiny radioactive beads) are used in real-world medical practice to treat liver cancer in France. Over 300 adults with primary or secondary liver tumors were included. The goal was to describe the treatment context, track side effects, and measure effectiveness, to help health authorities decide on continued reimbursement.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

CHRU de Strasbourg

Strasbourg, France
CHU d'Angers

Angers, France
CHU de Bordeaux

Bordeaux, France
CHU de Grenoble Alpes

Grenoble, France
CHU de Lyon

Lyon, France
CHU de Nimes

Nîmes, France
CHU de Poitiers

Poitiers, France
Centre Léon Bérard

Lyon, France
Chu de Dijon

Dijon, France
Hôpital Beaujon

Clichy, France
Hôpital Henri Mondor

Créteil, France
Institut Gustave Roussy

Paris, France
Institut Paoli-Calmettes

Marseille, France

Conditions

Explore the condition pages connected to this study.

LIVER CANCER